Biochemistry, Genetics and Molecular Biology
Lipolysis
95%
Growth Hormone
94%
Bovine Somatotropin
94%
Messenger RNA
80%
Skeletal Muscle
79%
Insulin Resistance
77%
Resveratrol
71%
Adipocyte
61%
Insulin Sensitivity
61%
Gene Expression
50%
Metabolic Pathway
49%
Lipid
47%
Uncoupling Protein
35%
Human
33%
Lipid Oxidation
32%
Triglyceride
30%
Lipopolysaccharide
27%
Normal Human
25%
Drug Megadose
25%
Alpha Oxidation
23%
Lipid Storage
21%
Cytokine
21%
Mouse
21%
Insulin Signaling
20%
Bone Density
20%
Erythropoietin
20%
Hormone-Sensitive Lipase
19%
Synapsin I
19%
Adipose Triglyceride Lipase
18%
Bone Turnover
18%
Protein Expression
18%
Lipid Metabolism
18%
Adiponectin
17%
Fat Mass
17%
Body Composition
17%
Lean Body Weight
17%
Vitamin D
16%
Leptin
16%
Protein Metabolism
16%
Angiopoietin
15%
Glucose Transport
15%
Pyruvate Dehydrogenase
15%
Growth Hormone Receptor
15%
Osteocalcin
15%
Controlled Clinical Trial
15%
Macrophage
14%
3T3-L1
14%
Free Fatty Acids
14%
Postmenopause
13%
FGF21
13%
Medicine and Dentistry
Adipose Tissue
65%
Placebo
58%
Growth Hormone
47%
Maturity Onset Diabetes of the Young
45%
Insulin Sensitivity
42%
Skeletal Muscle
41%
Lipolysis
39%
Insulin Resistance
39%
Gene Expression
35%
Bone Density
30%
Postmenopause
29%
Resveratrol
28%
Metabolic Syndrome
24%
Osteocalcin
24%
Brown Adipose Tissue
23%
Adipocyte
23%
Fatty Acid
22%
Acromegaly
20%
Biopsy
17%
Roux-en-Y Gastric Bypass
17%
Leptin
16%
Lipid Oxidation
16%
Vitamin K2
16%
In Vitro
15%
Muscle Biopsy
15%
Glycon
15%
Nonalcoholic Fatty Liver
15%
Protein Expression
15%
Glucose Metabolism
15%
Bone Turnover
14%
Placebo-Controlled Study
14%
Adiponectin
14%
Hypoglycemia
14%
Obstruction
13%
Controlled Clinical Trial
13%
Growth Hormone Receptor
13%
Bleeding
13%
Menaquinone
13%
Macrophage
13%
Erythropoietin
13%
Tau
13%
FGF21
13%
Disease
13%
Brown Adipocyte
13%
Insulin Signaling
13%
Glucose Uptake
12%
Uncoupling Protein 1
12%
Supplementation
11%
Parathyroid Hormone
11%
Hematinic
10%
Pharmacology, Toxicology and Pharmaceutical Science
Resveratrol
100%
Placebo
82%
Insulin Resistance
64%
Inflammation
50%
Nonalcoholic Fatty Liver
50%
Growth Hormone
49%
Vitamin D
31%
Non Insulin Dependent Diabetes Mellitus
28%
Metabolic Syndrome X
27%
Randomized Controlled Trial
24%
Fatty Acid
22%
Human
21%
Osteocalcin
19%
Uncoupling Protein 1
18%
Triacylglycerol
17%
Obstruction
16%
Farnoquinone
16%
Adiponectin
16%
Normal Human
15%
Controlled Clinical Trial
15%
Growth Hormone Receptor
14%
Randomized Clinical Trial
14%
Anti-Inflammatory Drug
14%
Metformin
13%
Acromegaly
13%
Angiopoietin Related Protein 4
13%
Bleeding
13%
Menaquinone
13%
Lipopolysaccharide
13%
Erythropoietin Receptor
13%
Diethylstilbestrol
13%
Very Low Density Lipoprotein
13%
Cytokine
13%
Hormone Sensitive Lipase
11%
Receptor
11%
Prevalence
11%
Palmitic Acid
10%
Antiinflammatory Activity
10%
Erythropoietin
10%
Hypovitaminosis D
10%
Vitamin D Deficiency
10%
Osteopenia
10%
Clinical Study
10%
Disease
10%
Leptin
10%
Placebo-Controlled Study
9%
Mouse
9%
Diabetes Mellitus
9%
Reperfusion Injury
9%
Pancreatic Lipase
9%
